News articles about Innospec (NASDAQ:IOSP) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innospec earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news articles about the specialty chemicals company an impact score of 45.5208667311886 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

A number of equities research analysts have commented on IOSP shares. Zacks Investment Research lowered Innospec from a “buy” rating to a “hold” rating and set a $63.00 price target on the stock. in a research report on Tuesday, September 12th. ValuEngine upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. KeyCorp reiterated an “overweight” rating on shares of Innospec in a research report on Thursday, November 9th. Monness Crespi & Hardt lowered Innospec from a “buy” rating to a “neutral” rating in a research report on Thursday, November 9th. Finally, Johnson Rice upgraded Innospec from a “hold” rating to an “accumulate” rating in a research report on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $70.50.

Shares of Innospec (NASDAQ IOSP) opened at $68.75 on Thursday. Innospec has a 52-week low of $54.10 and a 52-week high of $74.75. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.35 and a current ratio of 2.24. The company has a market capitalization of $1,660.00, a PE ratio of 16.21 and a beta of 1.20.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, November 7th. The specialty chemicals company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.85 by $0.15. Innospec had a return on equity of 15.05% and a net margin of 7.45%. The company had revenue of $332.40 million for the quarter, compared to analyst estimates of $309.40 million. During the same quarter in the prior year, the company earned $0.78 EPS. The firm’s revenue for the quarter was up 61.8% compared to the same quarter last year. research analysts forecast that Innospec will post 4.3 earnings per share for the current year.

The firm also recently announced a semiannual dividend, which was paid on Monday, November 27th. Investors of record on Thursday, November 16th were given a dividend of $0.39 per share. This is a positive change from Innospec’s previous semiannual dividend of $0.38. The ex-dividend date of this dividend was Wednesday, November 15th. This represents a dividend yield of 1.12%. Innospec’s dividend payout ratio is presently 21.55%.

In related news, CEO Patrick Williams sold 15,000 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $71.49, for a total transaction of $1,072,350.00. Following the sale, the chief executive officer now owns 174,242 shares in the company, valued at approximately $12,456,560.58. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Brian Watt sold 440 shares of the company’s stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $70.17, for a total value of $30,874.80. Following the sale, the vice president now owns 30,730 shares in the company, valued at approximately $2,156,324.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,366 shares of company stock worth $1,743,891. 2.02% of the stock is owned by corporate insiders.

WARNING: “Innospec (IOSP) Given Coverage Optimism Rating of 0.15” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/12/21/innospec-iosp-given-coverage-optimism-rating-of-0-15.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.